Your browser doesn't support javascript.
loading
Outcomes of iStent versus endocyclophotocoagulation (ECP) as adjunct to cataract surgery by phacoemulsification for glaucoma patients.
Algorinees, Rakan; Almohizea, Asma; Aldalgan, Hind; Alobaida, Ibrahim; Schargel, Konrad; Aljohar, Seham.
Afiliación
  • Algorinees R; Glaucoma Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
  • Almohizea A; Faculty of Ophthalmology, College of Medicine, University of Ha'il, Ha'il, Saudi Arabia.
  • Aldalgan H; Glaucoma Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
  • Alobaida I; Faculty of Ophthalmology, College of Medicine, Imam Abdulrahman bin Faisal university, Al Khobar, Saudi Arabia.
  • Schargel K; Glaucoma Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
  • Aljohar S; Glaucoma Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Eur J Ophthalmol ; : 11206721241261418, 2024 Jun 11.
Article en En | MEDLINE | ID: mdl-38860310
ABSTRACT

PURPOSE:

To compare the efficacy and safety of iStent versus Endocyclophotocoagulation (ECP) as an adjunct to cataract surgery by Phacoemulsification for treating glaucoma patients in a tertiary eye center.

METHODS:

Retrospective study of 67 eyes of 61 patients with glaucoma and cataract who underwent either phaco-ECP or phaco-iStent. Primary efficacy endpoint is the Intraocular pressure (IOP) reduction, while reduction of glaucoma medications is the secondary outcome. In addition to IOP and number of glaucoma medications; visual acuity, degree of disc cupping, safety profiles were all assessed at different intervals up to 12 months.

RESULTS:

A total of 40 eyes underwent phaco-ECP, and 27 eyes underwent phaco-iStent. Both groups were associated with a significant reduction in the number of glaucoma medications; however phaco-iStent group achieved slightly lower IOP levels than the phaco-ECP group. Furthermore, iStent inject had better control of IOP at the last follow-up compared to first-generation stents. Moreover; 2 or more stents significantly reduced IOP than single stent (p = 0.009 vs. p = 0.618, respectively). Phaco-iStent achieved a better reduction in the number of glaucoma medications for primary open-angle glaucoma (p = 0.007) compared to pseudoexfoliation glaucoma patients (p = 0.084). Complications were seen in 12 eyes (18%), of which five eyes in phaco-ECP (7.4%) and 7 eyes in phaco-iStent (10.4%), majority were mild and treated conservatively.

CONCLUSIONS:

Both groups had equal efficacy in reducing the IOP. However, phaco-iStent seems superior in reducing the number of glaucoma medications after 1 year of follow-up compared to phaco-ECP, particularly when 2 or more stents are used. Both groups showed an overall good safety profile.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur J Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur J Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Estados Unidos